Updated Figures, page-40

10c+ easily, depending on how long one is looking to hold.

IME has been around for quite a few years now, even if only recently listed. It has raked up scores of contracts with countless wins coming from renewals and new contracts with over 190 Customers in 5 Countries thus far.

The FDA application has been on my radar since I bought my first parcel back on the 19th of September. But it's not just the FDA approval that will re-rate, but the vast sea of new opportunities available in the mammoth US market once completed that's the real prize here.

Yes the appointment of Dr Lingard (and his recent purchases) are an incredible vote of confidence, but don't forget the wealth of experience our other board members bring to the table. Each have the right skill set and are of a high enough calibre to make this a truly global company.

Tom Pascarella's experience will be invaluable when dealing with the US expansion just as Dr Lingard's contacts will be here at home.

IMHO, we have the beginnings of an incredible business that, if managed correctly, could be a genuine wealth builder.